1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Substance Abuse Treatment Market  - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Substance Abuse Treatment Industry in U.S.: Forecasts to 2024

  • March 2017
  • 74 pages
  • ID: 4833600
In this report:
This section also provides the overall information and data analysis of the U.S. substance abuse treatment market with respect to the leading market segments based on abuse type, treatment type, end-users, and region.
Outpatient treatment centers is expected to be the most lucrative end-user segment and anticipated to expand at highest CAGR during the forecast period.

Summary

Table of Contents

U.S. Substance Abuse Treatment Market: Summary

This market report on substance abuse treatment, studies the current as well as future prospects of the market across the U.S. Substance abuse refers to the harmful or hazardous use of psychoactive substances, containing illicit drugs and alcohol. Excessive use of psychoactive substance can lead to dependence syndrome, that include a strong desire to take drug, difficulties in controlling its use, increased tolerance and sometimes a physical withdrawal state.

This business report comprises a detailed executive summary together with a market snapshot providing global information of different segments and subsegments considered within the coverage of the report. This section also offers the global information and data analysis of the U.S. substance abuse treatment market with respect to the leading market segments established on abuse type, treatment type, consumers, and region.

The analysis is a combination of primary and secondary research. Primary research formed the bulk of our research efforts, with info collected from telephonic interviews and interactions via e-mail. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and several national and worldwide databases.

The market research offers market value in terms of US$ Mn for each section for the time span from 2016 to 2024, examining the macro and micro-environmental factors. Growth rates for each division within the substance abuse treatment market have been determined after a thorough analysis of past trends, demographics, next trends, technological developments, expenditure, and regulatory requirements.

The section 'market overview' of this report includes qualitative analysis of the global substance abuse treatment market containing the determining factors and market dynamics including drivers, market restraints, market trends and alternatives, together with white space analysis. Additionally, Analysis of market appeal by country, isotopic application and consuemr together with opposing landscape by top players have been provided which explain the intensity of competition in the sector examining distinct geographical locations. The ambitious scenario between market actors has been evaluated through market share review. These aspects would benefit the key market players take tactical decisions in order to enhance their positions and increase their shares in the overall market.

U.S. Substance Abuse Treatment Market: Segmentation

The U.S. substance abuse treatment market has been studied based on abuse type, treatment type, and end-users segments. In terms of abuse type, substance abuse treatment market is split into alcohol dependence, tobacco/nicotine addiction, and opioid addiction. Based on treatment type, substance abuse treatment market is farther split into alcohol addiction treatment, tobacco or Nicotine addiction treatment and drug abuse treatment. Alcohol addiction treatment is farther bifurcated into widely preferred drugs, which comprises Disulfiram, Acamprosate and Naltrexone. Tobacco or Nicotine addiction treatment segment is farther divided into Nicotine Replacement Treatment and Non-Nicotine Medications.

Nicotine Patch, Nicotine Gum, Nicotine Lozenge, Nicotine Spray, Nicotine Inhaler are the OTCs preferred by addicted considered under Nicotine Replacement Treatment sub-segment. While, Bupropion and Varenicline are the medications used to treat nicotine addiction comes under Non-Nicotine Medications sub-segment. Drug abuse treatment segment is farther divided into Methadone, Buprenorphine, and Naltrexone. End-user segment of substance abuse treatment market is divided into outpatient treatment centers, residential treatment centers, and inpatient treatment centers. Outpatient treatment centers is forecast to be the most lucrative end-user segment and anticipated to expand at more important Compound annual growth rate during the outlook period.

The industry for these segments has been comprehensively studied based on their utility, effectiveness, sales, and geographic presence. Market income in terms of US$ Mn for the time span from 2014 to 2024 along with the CAGR from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

U.S. Substance Abuse Treatment Market: Competitive Analysis

A list of recommendations has been specified for additional entrants as well as existing market players to help them establish a strong presence in the sector and increase their share. The report also profiles main players of the substance abuse treatment market based on different attributes including company overview, financial review, strategic management, product portfolio and recent evolutions. Some of the Main actors described in this study include Alkermes, Allergan plc, Cipla Ltd, GlaxoSmithKline plc, Pfizer, Incorporated, Dr. Reddy's Laboratories Ltd., Sanofi, Purdue Pharma L.P., Mallinckrodt.

By Geography

The USA

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Nicotine Addiction R&D Pipeline Analysis Report, H2-2018

Nicotine Addiction R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • Industry report
  • August 2018
  • by VPAResearch

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studiesNicotine Addiction Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of ...

Nicotine Addiction Ongoing Global Clinical Trials Analysis and Outlook

Nicotine Addiction Ongoing Global Clinical Trials Analysis and Outlook

  • $ 700
  • Industry report
  • June 2018
  • by VPAResearch

Nicotine Addiction ongoing clinical trials report provides comprehensive analysis and trends in global Nicotine Addiction disease clinical trials. The research work analyzes the ongoing Nicotine Addiction ...

The 2019-2024 Outlook for Herbal Smoking Cessation Aids in the United States

The 2019-2024 Outlook for Herbal Smoking Cessation Aids in the United States

  • $ 595
  • Industry report
  • June 2018
  • by ICON Group

This study covers the latent demand outlook for herbal smoking cessation aids across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings ...


Download Unlimited Documents from Trusted Public Sources

Cardiovascular Disease Statistics in the US

  • September 2018
    9 pages
  • Cardiovascular ...  

    Salicylic Acid  

    Pain Relief  

  • United States  

    North America  

View report >

Smoking Cessation Demographic Impact in the US

  • September 2018
    8 pages
  • Smoking Cessati...  

  • United States  

View report >

Smoking Cessation Industry in Canada

  • June 2018
    5 pages
  • Smoking Cessati...  

    Cancer  

  • Canada  

    North America  

View report >

OTC Industry in the UK 8 months ago


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on